| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.097 | 0.08 |